# US 2026/0063641 A1 · Compositions and methods for labeling and detecting binding partners

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0063641 A1
- Document ID: US20260063641A1
- Status: Published application
- Kind: A1
- Application number: 19/100,557
- Filed: 2023-08-01
- Published: 2026-03-05
- Earliest claimed: 2022-08-01
- Applicants: University of Utah Research Foundation; The Regents of the University of California
- Inventors: Justin G. ENGLISH; Fleur FERGUSON
- Web page: https://patentgrep.com/patent/US20260063641A1

## CPC

- C12N 9/93: {Ligases (6)}
- G01N 33/581: {with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)}
- G01N 33/582: {with fluorescent label}
- G01N 33/6845: {Methods of identifying protein-protein interactions in protein mixtures}
- G01N 33/94: involving narcotics {or drugs or pharmaceuticals, neurotransmitters or associated receptors}
- G01N 2333/9015: Ligases (6)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Disclosed are compositions comprising a ligandable tag, a linker, and a labeling enzyme, wherein the linker attaches the ligandable tag to the labeling enzyme. Disclosed are nucleic acid sequences capable of encoding one or more of the disclosed protein based compositions. Disclosed are compositions comprising a ligand conjugated to a molecule of interest. Disclosed are systems comprising a labeling composition and a targeting composition, wherein the labeling composition comprises a ligandable tag, a linker, and a labeling enzyme, wherein the linker attaches the ligandable tag to the labeling enzyme, wherein the targeting composition comprises a ligand conjugated to a molecule of interest, wherein the ligand of the targeting composition is a ligand for the ligandable tag of the labeling composition. Disclosed are methods of using the disclosed compositions and systems.

## Claims

### Claim 1

A composition comprising a ligandable tag, a linker, and a labeling enzyme, wherein the linker attaches the ligandable tag to the labeling enzyme.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the labeling enzyme is an enzyme which can label a protein for biochemical analysis.

### Claim 3 (depends on 2)

The composition of claim 2, wherein the labeling enzyme is a protein having ligase activity.

### Claim 4 (depends on 3)

The composition of claim 3, wherein the protein having ligase activity is a biotin ligase.

### Claim 5 (depends on 4)

The composition of claim 4, wherein the biotin ligase is miniTurboID, TurboID, AirID, splitTurboID, or BirA.

### Claim 6 (depends on 3)

The composition of claim 3, wherein the protein having ligase activity is Formlyglycine, sortase, transglutaminase, farnesyltransferase, APEX, or lipoic acid ligase.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The composition of any one of claims 1-6, wherein the ligandable tag is a peptide or nucleic acid.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The composition of any one of claims 1-7, wherein the ligandable tag is FKBP12F36V.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7)

The composition of any one of claims 1-7, wherein the ligandable tag is HaloTAG, SNAp-tag, CLIp-TAG, LigandLink, or cutinase.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The composition of any one of claims 1-9, wherein the linker is a flexible linker.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The composition of any one of claims 1-10, wherein the linker is 6×(GSS)

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The composition of any one of claims 1-11, wherein the linker attaches the C-terminal end of the labeling enzyme with the N-terminal end of the ligandable tag.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The composition of any one of claims 1-11, wherein the linker attaches the N-terminal end of the labeling enzyme with the N-terminal end of the ligandable tag.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The composition of any one of claims 1-11, wherein the linker attaches the C-terminal end of the labeling enzyme with the C-terminal end of the ligandable tag.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The composition of any one of claims 1-11, wherein the linker attaches the N-terminal end of the labeling enzyme with the C-terminal end of the ligandable tag.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The composition of any one of claims 1-15, further comprising a detection moiety or a purification moiety.

### Claim 17 (depends on 16)

The composition of claim 16, wherein the detection moiety or purification moiety is a fluorescent molecule, biotin, streptavidin, c-myc, HA, GST, histidines.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

A nucleic acid construct capable of encoding the composition of any one of claims 1-17.

### Claim 19

A nucleic acid construct comprising a nucleic acid sequence capable of encoding a ligandable tag, a nucleic acid sequence capable of encoding a linker, and a nucleic acid sequence capable of encoding a labeling enzyme.

### Claim 20 (depends on 18, 19)

The nucleic acid construct of claims 18-19, further comprising a promoter.

### Claim 21 (depends on 20)

The nucleic acid construct of claim 20, wherein the promoter is an inducible promoter.

### Claim 22 (depends on 20)

The nucleic acid construct of claim 20, wherein the promoter is PGK.

### Claim 23 (depends on 19, 20, 21, 22)

The nucleic acid construct of any one of claims 19-22, further comprising a nucleic acid sequence capable of encoding a detection moiety or purification moiety.

### Claim 24 (depends on 23)

The nucleic acid construct of claim 23, wherein the detection moiety or purification moiety is a fluorescent molecule, biotin, c-myc, HA, GST, histidines.

### Claim 25 (depends on 18, 19, 20, 21, 22, 23, 24)

A vector comprising the nucleic acid construct of claims 18-24.

### Claim 26 (depends on 25)

The vector of claim 25, wherein the vector is an expression vector.

### Claim 27 (depends on 26)

The vector of claim 26, wherein the expression vector is a viral vector.

### Claim 28

A composition comprising a ligand conjugated to a molecule of interest.

### Claim 29 (depends on 28)

The composition of claim 28, wherein the composition comprises a linker between the ligand and molecule of interest.

### Claim 30 (depends on 29)

The composition of claim 29, wherein the linker is a chemical linker.

### Claim 31 (depends on 28, 29, 30)

The composition of any one of claims 28-30, wherein the ligand is Ortho-AP1867.

### Claim 32 (depends on 28, 29, 30, 31)

The composition of any one of claims 28-31, wherein the ligand is a HaloTag ligand.

### Claim 33 (depends on 32)

The composition of claim 32, wherein the HaloTag ligand is a haloalkane.

### Claim 34 (depends on 28, 29, 30, 31, 32, 33)

The composition of any one of claims 28-33, wherein the molecule of interest is ribociclib.

### Claim 35 (depends on 28, 29, 30, 31, 32, 33)

The composition of any one of claims 28-33, wherein the molecule of interest is (+)-S-JQ1.

### Claim 36 (depends on 28, 29, 30, 31, 32, 33)

The composition of any one of claims 28-33, wherein the molecule of interest is trametinib.

### Claim 37

A composition comprising the structure of

### Claim 38

A composition comprising the structure of

### Claim 39

A composition comprising the structure of

### Claim 40

A composition comprising the structure of

### Claim 41

A system comprising a labeling composition and a targeting composition,
wherein the labeling composition comprises a ligandable tag, a linker, and a labeling enzyme, wherein the linker attaches the ligandable tag to the labeling enzyme,
wherein the targeting composition comprises a ligand conjugated to a molecule of interest,
wherein the ligand of the targeting composition is a ligand for the ligandable tag of the labeling composition.

### Claim 42 (depends on 41)

The system of claim 41, wherein the labeling composition and the targeting composition are bound to each other.

### Claim 43

A method of detecting a binding partner of a molecule of interest comprising
a) adding a labeling composition and a target composition to a sample,
wherein the labeling composition comprises a ligandable tag conjugated to a labeling enzyme,
wherein the target composition comprises a ligand and a molecule of interest,
wherein the ligand of the target composition is a ligand for the ligandable tag of the labeling composition;
b) incubating the labeling composition and target composition with the sample under conditions that allow the molecule of interest to bind to a binding partner in the sample, wherein when the molecule of interest binds to a binding partner in the sample, the labeling enzyme labels the binding partner,
c) detecting the presence of the label in the sample,
wherein the presence of a label is indicative of a binding partner of a molecule of interest present in the sample.

### Claim 44 (depends on 43)

The method of claim 43, wherein the labeling composition is added to a cell of the sample using transfection, transduction, or genetic engineering.

### Claim 45 (depends on 43, 44)

The method of any one of claims 43-44, wherein the labeling enzyme is any enzyme which can label a protein for biochemical analysis.

### Claim 46 (depends on 43, 44, 45)

The method of any one of claims 43-45, wherein the labeling enzyme is a protein ligase.

### Claim 47 (depends on 43, 44, 45, 46)

The method of any one of claims 43-46, wherein the protein ligase is a biotin ligase.

### Claim 48 (depends on 47)

The method of claim 47, wherein the biotin ligase is miniTurboID, TurboID, or BirA.

### Claim 49 (depends on 47, 48)

The method of any one of claims 47-48, wherein the protein ligase is Formlyglycine, sortase, transglutaminase, famesyltransferase, or lipoic acid ligase.

### Claim 50 (depends on 43, 44, 45, 46, 47, 48, 49)

The method of any one of claims 43-49, wherein the ligandable tag is FKBPF36V.

### Claim 51 (depends on 43, 44, 45, 46, 47, 48, 49, 50)

The method of any one of claims 43-50, wherein the ligandable tag is Halo TAG, SNAp-tag, CLIp-TAG, LigandLink, or cutinase.

### Claim 52 (depends on 43, 44, 45, 46, 47, 48, 49, 50, 51)

The method of any one of claims 43-51, wherein the composition comprises a linker between the ligand and molecule of interest.

### Claim 53 (depends on 52)

The method of claim 52, wherein the linker is a chemical linker.

### Claim 54

A method of identifying a binding partner of a molecule of interest comprising
a) adding a labeling composition and a targeting composition to a sample,
wherein the labeling composition comprises a ligandable tag, a linker, and a labeling enzyme, wherein the linker attaches the ligandable tag to the labeling enzyme,
wherein the targeting composition comprises a ligand conjugated to a molecule of interest,
wherein the ligand of the targeting composition is a ligand for the ligandable tag of the labeling composition;
b) incubating the labeling composition and targeting composition with the sample under conditions that allow the molecule of interest to bind to a binding partner in the sample, wherein when the molecule of interest binds to a binding partner in the sample, wherein the labeling enzyme labels the binding partner;
c) detecting the presence of the label in the sample, and
d) identifying the labeled binding partner.

### Claim 55 (depends on 54)

The method of claim 54, further comprising isolating the labeled binding partner from the molecule of interest prior to identifying.

### Claim 56 (depends on 54)

The method of claim 54, wherein identifying the labeled binding partner comprises isolating any labeled molecules from the sample.

### Claim 57 (depends on 54, 55, 56)

The method of any one of claims 54-56, wherein identifying the labeled binding partner comprises performing proteomics, immunoblotting, or imaging.

### Claim 58 (depends on 54, 55, 56, 57)

The method of any one of claims 54-57, wherein the labeling enzyme is a protein ligase.

### Claim 59 (depends on 58)

The method of claim 58, wherein the protein ligase is any enzyme which can label a protein for biochemical analysis.

### Claim 60 (depends on 54, 55, 56, 57, 58, 59)

The method of any one of claims 54-59, wherein the protein ligase is a biotin ligase.

### Claim 61 (depends on 60)

The method of claim 60, wherein the biotin ligase is miniTurboID, TurboID, or BirA.

### Claim 62 (depends on 54, 55, 56, 57, 58, 59, 60, 61)

The method of any one of claims 54-61, wherein the protein ligase is Formlyglycine, sortase, transglutaminase, famesyltransferase, APEX, or lipoic acid ligase.

### Claim 63 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62)

The method of any one of claims 54-62, wherein the ligandable tag is FKBP12F36V.

### Claim 64 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62, 63)

The method of any one of claims 54-63, wherein the ligandable tag is Halo TAG, SNAp-tag, CLIp-TAG, LigandLink, or cutinase.

### Claim 65 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64)

The method of any one of claims 54-64, wherein the composition comprises a linker between the ligand and molecule of interest.

### Claim 66 (depends on 65)

The method of claim 65, wherein the linker is a chemical linker.

### Claim 67 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66)

The method of any one of claims 54-66, wherein the ligand is Ortho-AP1867.
